Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27583154 | 0.94 | ALDH1A1 (0.50) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL5523432 | 0.92 | ALDH1A1 (0.52) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL29090806 | 0.91 | ALDH1A1 (0.47) | ALDH1A1ALOX15TSHRKDM4EKMT2A | |
| SCHEMBL27547208 | 0.91 | ALDH1A1 (0.47) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL9468429 | 0.91 | ALDH1A1 (0.50) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL28630802 | 0.89 | ALDH1A1 (0.49) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL27469326 | 0.89 | KDM4E (0.50) | ALDH1A1ALOX15TSHRKDM4EKMT2A | |
| SCHEMBL28630572 | 0.89 | ALDH1A1 (0.49) | ALDH1A1ALOX15AKR1C3TSHRKDM4E | |
| SCHEMBL125859 | 0.88 | NR4A2 (0.45) | ALDH1A1ALOX15TSHRHPGDSMN1; SMN2 | |
| Succinic Acid SCHEMBL22217135 | 0.88 | NR4A2 (0.45) | ALDH1A1ALOX15TSHRHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119044-A2 | ADRULIPASE COMPOSITIONS | First Wave BioPharma, Inc. (US) | 2024-06-06 | — | — | WO | claimed |
| US-9149439-B2 | Multi-particulate, modified-release composition | SANDOZ AG (CH) | 2015-10-06 | — | — | US | claimed |
| CN-103804906-A | Improved PPA plastic | SUZHOU HANXIN PLASTIC INDUSTRY CO LTD | 2014-05-21 | — | — | CN | claimed |
| EP-2507203-A1 | NEW PROCESS FOR THE PREPARATION OF TAPENTADOL AND INTERMEDIATES THEREOF | Euticals S.P.A. (IT) | 2012-10-10 | — | — | EP | claimed |
| US-8168228-B2 | Oral micropellets containing an antibiotic having an inner coating of a cellulose polymer (not enteric)and an outer coating of an enteric coating polymer; particle size of 100 to 650 mu m.; lack of bitter taste; fast dissolution; increased antibiotic bioavailability compared pellets having a matrix | SANDOZ AG (CH) | 2012-05-01 | — | — | US | claimed |
| WO-2011067714-A1 | NEW PROCESS FOR THE PREPARATION OF TAPENTADOL AND INTERMEDIATES THEREOF | ARCHIMICA SRL (IT) | 2011-06-09 | — | — | WO | claimed |
| US-20100215747-A1 | NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS | BEND RESEARCH, INC. | 2010-08-26 | — | — | US | claimed |
| EP-2178518-A2 | NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS | Bend Research, Inc (US) | 2010-04-28 | — | — | EP | claimed |
| WO-2009010842-A2 | NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS | PFIZER PRODUCTS INC. (US) | 2009-01-22 | — | — | WO | claimed |
| EP-1680088-B1 | Taste-masked formulation comprising clarithromycin | SANDOZ AG (CH) | 2008-12-03 | — | — | EP | claimed |
| US-20070048379-A1 | Valproate tablet | GUO MINTONG | 2007-03-01 | — | — | US | claimed |
| CN-1893927-A | Antibiotic composition | SANDOZ AG (CH) | 2007-01-10 | — | — | CN | claimed |
| WO-2006102446-A2 | MULTI-PARTICULATE, MODIFIED-RELEASED COLONIC COMPOSITION | SANDOZ AG (CH) | 2006-09-28 | — | — | WO | claimed |
| US-20060210631-A1 | Multi-particulate, modified-release composition | SANDOZ AG (CH) | 2006-09-21 | — | — | US | claimed |
| EP-1680088-A1 | ANTIBIOTIC COMPOSITIONS | Sandoz AG (CH) | 2006-07-19 | — | — | EP | claimed |
| WO-2005077342-A1 | ENTERICALLY COATED LANSOPRAZOLE MICROTABLETS | SANDOZ AG (CH) | 2005-08-25 | — | — | WO | claimed |
| US-20050181052-A1 | Lansoprazole microtablets | PATEL SATISHKUMAR A (US) | 2005-08-18 | — | — | US | claimed |
| WO-2005039536-A1 | ANTIBIOTIC COMPOSITIONS | SANDOZ AG (CH) | 2005-05-06 | — | — | WO | claimed |
| US-20050084540-A1 | Oral micropellets containing an antibiotic having an inner coating of a cellulose polymer (not enteric)and an outer coating of an enteric coating polymer; particle size of 100 to 650 mu m.; lack of bitter taste; fast dissolution; increased antibiotic bioavailability compared pellets having a matrix | SANDOZ INC. | 2005-04-21 | — | — | US | claimed |
| US-20050084541-A1 | Antibiotic compositions | SANDOZ, AG (CH) | 2005-04-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215747-A1 | NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS | CEL, GYS1, TNNC1 | ALDH1A1 3658/4885ALOX15 2345/4885AKR1C3 3743/4885 |
| US-20070048379-A1 | Valproate tablet | CACNA1A, SUCLG2, CACNA1G | ALDH1A1 1386/4885ALOX15 3316/4885AKR1C3 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.